Table 1.
Clinical characteristics of the study participants. 1
| Case | Control | p-Value | |
|---|---|---|---|
| Participants, N | 83 | 88 | |
| Sex, Nfemale (%) | 58 (70) | 62 (70) | 1.000 |
| Age, median (min-max) | 52 (29–77) | 50 (28–77) | 0.830 |
| Type of multiple sclerosis, N (%) | |||
| Relapsing remitting | 31 (37) | ||
| Secondary progressive with relapses | 25 (30) | ||
| Secondary progressive without relapses | 15 (18) | ||
| Primary progressive | 12 (14) | ||
| Expanded Disability Status Scale, median (IQR) | |||
| Relapsing remitting | 2.0 (1.0–4.5) | ||
| Secondary progressive with relapses | 6.0 (5.0–8.0) | ||
| Secondary progressive without relapses | 6.5 (6.0–7.5) | ||
| Primary progressive | 6.0 (6.0–7.5) | ||
1 Difference in sex was tested using Fisher-exact test, while difference in age was tested using Wilcoxon rank-sum test. IQR—interquartile range.